WCDD-301

N/A

Report date: 2025/01/26 15:15:29
NME

Base Information

Drug NameWCDD-301
Drug Alias NameWCDD-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionErythropoietin-producing hepatocellular receptor A4 stimulants
TargetsErythropoietin-producing hepatocellular receptor A4
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWashington University
China Registration ClassN/A

Develop Information

Active CompaniesWashington University
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A